相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2012)
Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
Eun Joo Lee et al.
ACTA RADIOLOGICA (2011)
Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer
S. H. Chandrashekhara et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer
M. Deraco et al.
EJSO (2011)
Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management
John Spiliotis et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Quantitative Detection of Serum Survivin and Its Relationship with Prognostic Factors in Ovarian Cancer
Jae Hong No et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2011)
CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
Nicole D. Fleming et al.
GYNECOLOGIC ONCOLOGY (2011)
HIPEC in recurrent ovarian cancer patients: Morbidity-related treatment and long-term analysis of clinical outcome
Anna Fagotti et al.
GYNECOLOGIC ONCOLOGY (2011)
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study
Kian Behbakht et al.
GYNECOLOGIC ONCOLOGY (2011)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial
Marcello Deraco et al.
GYNECOLOGIC ONCOLOGY (2011)
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO
Philipp Harter et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?
Leslie S. Bradford et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Role of Computed Tomography in the Surgical Management of Patients with Bowel Obstruction Secondary to Recurrent Ovarian Carcinoma
J. Alejandro Rauh-Hain et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review
N. B. Rettenmaier et al.
BRITISH JOURNAL OF CANCER (2010)
Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer
L. Woelber et al.
EJSO (2010)
Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study
C. Pomel et al.
EJSO (2010)
Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
C. G. Gerestein et al.
EUROPEAN JOURNAL OF CANCER (2010)
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas
Dennis S. Chi et al.
GYNECOLOGIC ONCOLOGY (2010)
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
M. Robyn Andersen et al.
GYNECOLOGIC ONCOLOGY (2010)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer First Report of the HYPER-O Registry
Cyril William Helm et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
Andreas du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies
Robert A. Burger
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Role of Secondary Cytoreductive Surgery in Ovarian Cancer Relapse: Who Will Benefit? A Systematic Analysis of 240 Consecutive Patients
Jalid Sehouli et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Origin of Ovarian Cancer May Have Implications for Screening
Rabiya S. Tuma
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Diffusion-weighted Imaging of Peritoneal Disease for Noninvasive Staging of Advanced Ovarian Cancer
Stavroula Kyriazi et al.
RADIOGRAPHICS (2010)
Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients' Survival
Evis Sala et al.
RADIOLOGY (2010)
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer
N. Carrabin et al.
BULLETIN DU CANCER (2010)
β3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
Swayamjot Kaur et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Surgery for Recurrent Ovarian Cancer: Role of Peritoneal Carcinomatosis: Exploratory Analysis of the DESKTOP I Trial About Risk Factors, Surgical Implications, and Prognostic Value of Peritoneal Carcinomatosis
P. Harter et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Role of cytoreductive surgery in recurrent ovarian cancer
Philipp Harter et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review
Cornelis G. Gerestein et al.
GYNECOLOGIC ONCOLOGY (2009)
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study
A. Fagotti et al.
GYNECOLOGIC ONCOLOGY (2009)
The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project
M. J. Fulham et al.
GYNECOLOGIC ONCOLOGY (2009)
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Robert E. Bristow et al.
GYNECOLOGIC ONCOLOGY (2009)
The clonal evolution of metastases from primary serous epithelial ovarian cancers
Lalarukh Khalique et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Intra-Abdominal Tumor Dissemination Pattern and Surgical Outcome in 214 Patients With Primary Ovarian Cancer
Jalid Sehouli et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Intraperitoneal Therapy for Ovarian Cancer: Why Has It Not Become Standard?
Karen Rowan
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
C. William Helm
ONCOLOGIST (2009)
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer
Angelo Di Giorgio et al.
CANCER (2008)
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma
Jee Young Hwang et al.
CANCER RESEARCH (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: A trial of the California, Chicago, and princess Margaret hospital phase II consortia
Agustin A. Garcia et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Learning curve of combined modality treatment in peritoneal surface disease
R. M. Smeenk et al.
BRITISH JOURNAL OF SURGERY (2007)
Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery
Jeong Hoon Bae et al.
GYNECOLOGIC ONCOLOGY (2007)
Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma
C. William Helm et al.
GYNECOLOGIC ONCOLOGY (2007)
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
Pierluigi Benedetti Panici et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Development of an ovarian cancer symptom index - Possibilities for earlier detection
Barbara A. Goff et al.
CANCER (2007)
Surgery in recurrent ovarian cancer:: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Philipp Harter et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer:: An intergroup trial of the AGO-OVAR, the NCICCTG, and the EORTC GCG
Jacobus Pfisterer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer
Sebastian Rufian et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan
F. Raspagliesi et al.
EJSO (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
PB Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Snail, slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
S Elloul et al.
CANCER (2005)
Intraperitoneal hyperthermic chemotherapy in ovarian cancer
J Gori et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum
B Gronlund et al.
EJSO (2005)
The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence
P Harter et al.
CURRENT OPINION IN ONCOLOGY (2005)
Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens
RJ Amato
ANNALS OF ONCOLOGY (2005)
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers
KM Burleson et al.
GYNECOLOGIC ONCOLOGY (2004)
Role of CT in the management of recurrent ovarian cancer
SA Funt et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma
N Nishida et al.
CANCER (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers
KM Burleson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer
C Zanon et al.
WORLD JOURNAL OF SURGERY (2004)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Staging ovarian cancer: role of imaging
FV Coakley
RADIOLOGIC CLINICS OF NORTH AMERICA (2002)
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: Application toward a dynamic disease state model of ovarian cancer
DS Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer
SM Eisenkop et al.
GYNECOLOGIC ONCOLOGY (2001)
Analysis of treatment failures and survival of patients with Fallopian tube carcinoma: A cooperation task force (CTF) study
A Gadducci et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
